Young Kwon
CIK: 0001733094
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADMA
ADMA BIOLOGICS, INC.
Director
Discretionary Trading P&L
Holdings
About KWON YOUNG
KWON YOUNG (SEC CIK 0001733094) files insider reports with the SEC as Director of ADMA BIOLOGICS, INC. (ADMA).
Signal8 holds 2 ownership filings by KWON YOUNG, all Form 4s, filed between Feb 21, 2025 and Feb 11, 2026. Those filings report 2 transactions, from Feb 19, 2025 to Feb 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KWON YOUNG's filings is in RAMSEY, NJ.
Recent filings by KWON YOUNG
Other insiders filing for ADMA BIOLOGICS, INC. (ADMA)
- Kestenberg-Messina Kaitlin M., COO and SVP, Compliance
- Kohler Terry, CFO and Treasurer
- Grossman Jerrold B, Director
- Guiheen Lawrence P., Director
- Grossman Adam S, President and CEO
- ELMS STEVE, Director